Publications

Publications by Stig Ove Bøe

28 publications found

Publications 2019

  1. Lång A, Lång E, Bøe SO (2019)
    PML Bodies in Mitosis
    Cells, 8 (8)
    DOI 10.3390/cells8080893, PubMed 31416160

Publications 2018

  1. Herrera MC, Chymkowitch P, Robertson JM, Eriksson J, Bøe SO, Alseth I, Enserink JM (2018)
    Cdk1 gates cell cycle-dependent tRNA synthesis by regulating RNA polymerase III activity
    Nucleic Acids Res, 46 (22), 11698-11711
    DOI 10.1093/nar/gky846, PubMed 30247619
  2. Herrera MC, Chymkowitch P, Robertson JM, Eriksson J, Bøe SO, Alseth I, Enserink JM (2018)
    Corrigendum: Cdk1 gates cell cycle-dependent tRNA synthesis by regulating RNA polymerase III activity
    Nucleic Acids Res, 46 (22), 12188-12189
    DOI 10.1093/nar/gky1102, PubMed 30395271
  3. Lång A, Øye A, Eriksson J, Rowe AD, Lång E, Bøe SO (2018)
    Influence of acute promyelocytic leukemia therapeutic drugs on nuclear pore complex density and integrity
    Biochem Biophys Res Commun, 499 (3), 570-576
    DOI 10.1016/j.bbrc.2018.03.191, PubMed 29596829
  4. Lång E, Połeć A, Lång A, Valk M, Blicher P, Rowe AD, Tønseth KA, Jackson CJ, Utheim TP, Janssen LMC, Eriksson J, Bøe SO (2018)
    Coordinated collective migration and asymmetric cell division in confluent human keratinocytes without wounding
    Nat Commun, 9 (1), 3665
    DOI 10.1038/s41467-018-05578-7, PubMed 30202009

Publications 2017

  1. Delbarre E, Ivanauskiene K, Spirkoski J, Shah A, Vekterud K, Moskaug JØ, Bøe SO, Wong LH, Küntziger T, Collas P (2017)
    PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX
    Genome Res, 27 (6), 913-921
    DOI 10.1101/gr.215830.116, PubMed 28341773
  2. Lång A, Eriksson J, Schink KO, Lång E, Blicher P, Połeć A, Brech A, Dalhus B, Bøe SO (2017)
    Visualization of PML nuclear import complexes reveals FG-repeat nucleoporins at cargo retrieval sites
    Nucleus, 8 (4), 404-420
    DOI 10.1080/19491034.2017.1306161, PubMed 28402725

Publications 2016

  1. Palibrk V, Suganthan R, Scheffler K, Wang W, Bjørås M, Bøe SO (2016)
    PML regulates neuroprotective innate immunity and neuroblast commitment in a hypoxic-ischemic encephalopathy model
    Cell Death Dis, 7 (7), e2320
    DOI 10.1038/cddis.2016.223, PubMed 27468695

Publications 2014

  1. Palibrk V, Lång E, Lång A, Schink KO, Rowe AD, Bøe SO (2014)
    Promyelocytic leukemia bodies tether to early endosomes during mitosis
    Cell Cycle, 13 (11), 1749-55
    DOI 10.4161/cc.28653, PubMed 24675887

Publications 2013

  1. Torgersen ML, Engedal N, Bøe SO, Hokland P, Simonsen A (2013)
    Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells
    Blood, 122 (14), 2467-76
    DOI 10.1182/blood-2013-05-500629, PubMed 23970379

Publications 2012

  1. Lång E, Grudic A, Pankiv S, Bruserud O, Simonsen A, Bjerkvig R, Bjørås M, Bøe SO (2012)
    The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling
    Blood, 120 (4), 847-57
    DOI 10.1182/blood-2011-10-388496, PubMed 22692509

Publications 2010

  1. Bøe SO, Simonsen A (2010)
    Autophagic degradation of an oncoprotein
    Autophagy, 6 (7), 964-5
    DOI 10.4161/auto.6.7.13066, PubMed 20724820
  2. Goplen D, Bougnaud S, Rajcevic U, Bøe SO, Skaftnesmo KO, Voges J, Enger PØ, Wang J, Tysnes BB, Laerum OD, Niclou S, Bjerkvig R (2010)
    αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells
    Am J Pathol, 177 (4), 1618-28
    DOI 10.2353/ajpath.2010.090063, PubMed 20813964
  3. Isakson P, Bjørås M, Bøe SO, Simonsen A (2010)
    Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
    Blood, 116 (13), 2324-31
    DOI 10.1182/blood-2010-01-261040, PubMed 20574048
  4. Jul-Larsen A, Grudic A, Bjerkvig R, Bøe SO (2010)
    Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein
    BMC Mol Biol, 11, 89
    DOI 10.1186/1471-2199-11-89, PubMed 21092142

Publications 2009

  1. Jul-Larsen A, Grudic A, Bjerkvig R, Bøe SO (2009)
    Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins
    J Cell Sci, 122 (Pt 8), 1201-10
    DOI 10.1242/jcs.040840, PubMed 19339552

Publications 2008

  1. Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R, Enger PØ (2008)
    CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
    Int J Cancer, 122 (4), 761-8
    DOI 10.1002/ijc.23130, PubMed 17955491

Publications 2007

  1. Grudic A, Jul-Larsen A, Haring SJ, Wold MS, Lønning PE, Bjerkvig R, Bøe SO (2007)
    Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres
    Nucleic Acids Res, 35 (21), 7267-78
    DOI 10.1093/nar/gkm738, PubMed 17959650

Publications 2006

  1. Bøe SO, Haave M, Jul-Larsen A, Grudic A, Bjerkvig R, Lønning PE (2006)
    Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA
    J Cell Sci, 119 (Pt 16), 3284-95
    DOI 10.1242/jcs.03068, PubMed 16868026

Publications 2004

  1. Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Bøe SO, Iversen BM, Bruserud Ø, Ulvestad E, Gjertsen BT (2004)
    Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease
    Scand J Immunol, 60 (1-2), 189-98
    DOI 10.1111/j.0300-9475.2004.01450.x, PubMed 15238089
  2. Jul-Larsen A, Visted T, Karlsen BO, Rinaldo CH, Bjerkvig R, Lønning PE, Bøe SO (2004)
    PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication
    Exp Cell Res, 298 (1), 58-73
    DOI 10.1016/j.yexcr.2004.03.045, PubMed 15242762

Publications 2002

  1. Bjørndal B, Helleland C, Bøe SO, Gudbrandsen OA, Kalland KH, Bohov P, Berge RK, Lillehaug JR (2002)
    Nuclear import of factors involved in signaling is inhibited in C3H/10T1/2 cells treated with tetradecylthioacetic acid
    J Lipid Res, 43 (10), 1630-40
    DOI 10.1194/jlr.m100406-jlr200, PubMed 12364547
  2. Cmarko D, Bøe SO, Scassellati C, Szilvay AM, Davanger S, Fu XD, Haukenes G, Kalland KH, Fakan S (2002)
    Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs
    J Virol, 76 (20), 10473-84
    DOI 10.1128/jvi.76.20.10473-10484.2002, PubMed 12239324

Publications 2000

  1. Bøe SO, Kalland KH (2000)
    Identification of a nuclear ribonucleoprotein particle which contains incompletely spliced HIV-1 RNAs
    Biochem Biophys Res Commun, 268 (2), 509-13
    DOI 10.1006/bbrc.2000.2177, PubMed 10679235

Publications 1999

  1. Szilvay AM, Bøe SO, Kalland KH (1999)
    Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs
    J Gen Virol, 80 ( Pt 8), 1965-74
    DOI 10.1099/0022-1317-80-8-1965, PubMed 10466792

Publications 1998

  1. Bøe SO, Bjørndal B, Røsok B, Szilvay AM, Kalland KH (1998)
    Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35
    Virology, 244 (2), 473-82
    DOI 10.1006/viro.1998.9110, PubMed 9601515

Publications 1997

  1. Szilvay AM, Brokstad KA, Bøe SO, Haukenes G, Kalland KH (1997)
    Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import
    Virology, 235 (1), 73-81
    DOI 10.1006/viro.1997.8671, PubMed 9300038

Publications 1995

  1. Bøe SO, Sodroski J, Helland DE, Farnet CM (1995)
    DNA end-joining in extracts from human cells
    Biochem Biophys Res Commun, 215 (3), 987-93
    DOI 10.1006/bbrc.1995.2561, PubMed 7488071
 
Page visits: 4042